1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Relapsed or Refractory Immune Thrombocytopenia: new trials by email Literature Review of Relapsed or Refractory Immune Thrombocytopenia trials Research Report on Relapsed or Refractory Immune Thrombocytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RN1201 Injection in the Treatment of Antibody-Mediated Diseases CD19 and BCMA-targeted allogeneic CAR-T cells - Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia | Phase 1 | Recruiting | The First Affiliated Hospital of Soochow University | 9 | 2025-07-07 | 2026-06-12 |
Purpura, Thrombocytopenic, Idiopathic (1) · Recurrence (1)
Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cytopenia (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Purpura (1) · Purpura, Thrombocytopenic (1) · Signs and Symptoms (1)
Antigens, CD19 (1)
The First Affiliated Hospital of Soochow University (1)
China (1)